{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:35:39Z","timestamp":1783114539782,"version":"3.54.6"},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"40","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,15]]},"DOI":"10.18632\/oncotarget.20317","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T12:04:01Z","timestamp":1503057841000},"page":"68863-68872","source":"Crossref","is-referenced-by-count":53,"title":["Diagnostic accuracy of BRCA1-associated protein 1 in malignant mesothelioma: a meta-analysis"],"prefix":"10.18632","volume":"8","author":[{"given":"Li-Ming","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Second People's Hospital of Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Wang","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Second People's Hospital of Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ling","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Second People's Hospital of Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Second People's Hospital of Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Bin","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Second People's Hospital of Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Bin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Second People's Hospital of Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Second People's Hospital of Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Lake","year":"2005","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcp.2016.07.012","article-title":"New therapeutic strategies for malignant pleural mesothelioma","volume":"123","author":"Alfieri","year":"2017","journal-title":"Biochem Pharacol"},{"key":"3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1586\/14737159.5.5.715","article-title":"Malignant mesothelioma: current status of histopathologic diagnosis and molecular profile","volume":"5","author":"Moran","year":"2005","journal-title":"Expert Rev Mol Diagn"},{"key":"4","first-page":"273","volume-title":"Textbook of lung cancer","author":"Hanson","year":"2000"},{"key":"5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccm.2006.01.004","article-title":"Management of malignant pleural mesothelioma","volume":"27","author":"Lee","year":"2006","journal-title":"Clin Chest Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/thx.2007.081430","article-title":"Population based epidemiology and prognosis of mesothelioma in Leeds","volume":"63","author":"Muers","year":"2008","journal-title":"UK. Thorax"},{"key":"7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/0284186X.2012.709948","article-title":"Treatment and survival analyses of malignant mesothelioma in Japan","volume":"52","author":"Kishimoto","year":"2013","journal-title":"Acta Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/hupa.2002.128248","article-title":"Immunohistochemical diagnosis of epithelioid mesotheliomas: a critical review of old markers, new markers","volume":"33","author":"Ord\u00f3\u00f1ez","year":"2002","journal-title":"Hum Pathol"},{"key":"9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.lungcan.2016.07.011","article-title":"Low homozygous\/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma","volume":"99","author":"Nabeshima","year":"2016","journal-title":"Lung Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2012.05.014","article-title":"Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update","volume":"44","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Hum Pathol"},{"key":"11","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Powers","year":"2011","journal-title":"Nat Genet"},{"key":"12","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Sekido","year":"2013","journal-title":"Carcinogenesis"},{"key":"13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","author":"Friedberg","year":"2012","journal-title":"J Transl Med"},{"key":"14","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.1228463","article-title":"Cancer. Emerging anatomy of the BAP1 tumor suppressor system","volume":"337","author":"Harper","year":"2012","journal-title":"Science"},{"key":"15","doi-asserted-by":"crossref","first-page":"59314","DOI":"10.18632\/oncotarget.10653","article-title":"Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma","volume":"7","author":"Pastorino","year":"2016","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","article-title":"Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens","volume":"40","author":"Churg","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Churg","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2015.12.012","article-title":"Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma","volume":"51","author":"Gill","year":"2016","journal-title":"Hum Pathol"},{"key":"19","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/modpathol.2015.87","article-title":"Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology","volume":"28","author":"Gill","year":"2015","journal-title":"Mod Pathol"},{"key":"20","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cavazza","year":"2015","journal-title":"Mod Pathol"},{"key":"21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jtho.2016.12.006","article-title":"Improving the Accuracy of Mesothelioma Diagnosis in China","volume":"12","author":"Wang","year":"2017","journal-title":"J Thorac Oncol"},{"key":"22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry","volume":"104","author":"Nabeshima","year":"2017","journal-title":"Lung Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.annpat.2016.01.005","article-title":"BRCA1 associated protein 1 (BAP1) expression in pleural diffuse malignant mesothelioma: A comparative cytological and histological analyses on 50 patients","volume":"36","author":"Brevet","year":"2016","journal-title":"Ann Pathol"},{"key":"24","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","article-title":"BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma","volume":"46","author":"Krausz","year":"2015","journal-title":"Hum Pathol"},{"key":"25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/his.13123","article-title":"Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma","volume":"70","author":"Fukayama","year":"2017","journal-title":"Histopathol"},{"key":"26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/dc.23491","article-title":"BAP1 Immunostain and CDKN2A (p16) FISH Analysis: Clinical Applicability for the Diagnosis of Malignant Mesothelioma in Effusions","volume":"44","author":"Marchevsky","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/pin.12453","article-title":"BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests","volume":"66","author":"Nabeshima","year":"2016","journal-title":"Pathol Int"},{"key":"28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.humpath.2016.09.026","article-title":"BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma","volume":"60","author":"Krausz","year":"2017","journal-title":"Hum Pathol"},{"key":"29","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1378\/chest.06-2273","article-title":"Diagnostic value of interferon-gamma in tuberculous pleurisy: a meta analysis","volume":"131","author":"Qin","year":"2007","journal-title":"Chest"},{"key":"30","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.lungcan.2005.03.012","article-title":"Molecular prognostic markers in malignant mesothelioma","volume":"49","author":"Kratzke","year":"2005","journal-title":"Lung Cancer"},{"key":"31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Fraire","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5858\/arpa.2015-0240-SA","article-title":"New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?","volume":"140","author":"Galateau-Salle","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","article-title":"The diagnostic odds ratio: a single indicator of test performance","volume":"56","author":"Bossuyt","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmj.323.7305.157","article-title":"Systematic reviews in health care Systematic reviews of evaluations of diagnostic and screening tests","volume":"323","author":"Deeks","year":"2001","journal-title":"BMJ"},{"key":"35","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/PAS.0000000000000616","article-title":"BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas","volume":"40","author":"Churg","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12967-015-0485-1","article-title":"BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma","volume":"13","author":"Harismendy","year":"2015","journal-title":"J Transl Med"},{"key":"37","first-page":"25","article-title":"The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews","volume":"10","author":"Kleijnen","year":"2003","journal-title":"BMC Med Res Methodol"},{"key":"38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic","volume":"155","author":"Bossuyt","year":"2011","journal-title":"Ann Intern Med"},{"key":"39","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/sim.4780121403","article-title":"Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations","volume":"12","author":"Littenberg","year":"1993","journal-title":"Stat Med"},{"key":"40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Laird","year":"1986","journal-title":"Control Clin Trials"},{"key":"41","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Minder","year":"1997","journal-title":"BMJ"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T16:50:56Z","timestamp":1596732656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":41,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2017,9,15]]}},"alternative-id":["20317","28978163"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20317","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]}}}